Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes

Diabetes

Volumn 46, Issue 1, 1997, Pages 119-124

  Allen, Terri J ^a   Waldron, Matthew J ^a   Casley, David ^a   Jerums, George ^a   Cooper, Mark E ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; KIDNEY SIZE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; ALBUMINURIA; ANIMAL; BLOOD; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; KIDNEY; METABOLISM; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; REGRESSION ANALYSIS; SODIUM RESTRICTION; SPRAGUE DAWLEY RAT; TIME;

ANGIOTENSIN II; RENIN;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIET, SODIUM-RESTRICTED; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REGRESSION ANALYSIS; RENIN; TIME FACTORS;

EID: 0030636591     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.119     Document Type: Article

References (68)

1. Mogensen C, Andersen MJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706-712, 1973
2. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
3. Allen TJ, Cooper ME, O'Brien RC, Bach LA, Jackson B, Jerums G: Glomerular filtration rate in the streptozocin diabetic rat: the role of exchangeable sodium, vasoactive hormones and insulin therapy. Diabetes 38:1182-1190, 1990
4. Rudberg S, Persson B, Dahlquist G: Increased glomerular filtration rate as a predictor of diabetic nephropathy: an 8-year prospective study. Kidney Int 41:822-828, 1992
5. Mogensen CE: Glomerular hyperfiltration in human diabetes. Diabetes Care 17:770-775, 1994
6. Viberti GC, Jarrett RJ, Wiseman MJ: Predicting diabetic nephropathy. N Engl J Med 311:1256-1257, 1984
7. Lervang H, Jensen S, Brochner-Mortensen J, Ditzel J: Early glomerular hyperfiltration and the development of late nephropathy in type I (insulin-dependent) diabetes mellitus. Diabetologia 31:723-729, 1988
8. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
9. Wilkes BM, Mento PF, Vernace MA: Angiotensin responsiveness in hyperfiltering and nonhyperfiltering diabetic rats. J Am Soc Nephrol 4:1346-1353, 1993
10. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57:419-434, 1976
11. Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749-756, 1988
12. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17:626-635, 1991
13. Anderson PW, Do YS, Hsueh WA: Angiotensin II causes mesangial cell hypertrophy. Hypertension 21:29-35, 1993
14. Bank N, Lahorra MAG, Aynedjian HS, Schlondorff D: Vasoregulatory hormones and the hyperfiltration of diabetes. Am J Physiol 254:F202-F209, 1988
15. Bank N, Lahorra MAG, Aynedjian HS, Schlondorff D: Sodium restriction corrects hyperfiltration of diabetes. Am J Physiol 254:F668-F676, 1988
16. Benstein JA, Feiner H, Parker M, Dworkin L: Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomised SHR. Am J Physiol 258:F1675-F1681, 1990
17. Lax DS, Benstein JA, Tolbert E, Dworkin LD: Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 41:1527-1534, 1992
18. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282, 1973
19. Schmidt FH: Enzymatic determination of glucose and fructose simultaneously. Klin Woch 39:1244-1247, 1961
20. Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G: The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 38:387-394, 1995
21. Cooper ME, Rumble JR, Allen T, O'Brien RC, Jerums G, Doyle AE: Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int 41:898-903, 1992
22. Mendelsohn FAO, Hutchinson J, Johnston CI: A review of plasma renin measurements and their clinical significance. Aust NZ J Med 1:86-93, 1971
23. Johnston CI, Mendelsohn FAO, Casley DJ: Evaluation of renin and angiotensin assays and their clinical implications. Med J Aust 1:126-128, 1971
24. O'Brien RC, Allen TJ, Cooper ME, Bach LA, Jerums G: Glomerular filtration rate in early experimental diabetes. J Diabetic Complications 2:8-11, 1988
25. Snedecor GW, Cochran WG: Statistical methods. In Statistical Methods. 7th ed. Ames, IA, Iowa State University Press, 1980, p. 228-236
26. Hostetter TH: Diabetic nephropathy: metabolic versus hemodynamic considerations. Diabetes Care 15:1205-1215, 1992
27. Zatz R, Dunn BR, Meyer TW, Brenner B: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
28. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
29. Ballermann BJ, Skorecki KL, Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 247:F110-F116, 1984
30. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M: The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol 4:1337-1345, 1993
31. Christlieb AR: Vascular reactivity to angiotensin II and norepinephrine in diabetic subjects. Diabetes 25:268-274, 1976
32. Hill MA, Larkins RG: Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am J Physiol 257:H1438-H1445, 1989
33. Bjorck S, Aurell M, Bresater LE, Herlitz H, Welin L, Wikstrand J: Renal sensitivity to angiotensin II in human diabetes mellitus is not decreased (Abstract). Kidney Int 35:298, 1989
34. Hutchison FN, Cui X, Webster SK: The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol 6:1216-1222, 1995
35. Johnston CI, Clappison BH, Anderson WP, Yasujima M: Effect of angiotensin converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol 49:1401-1404, 1982
36. Vallon V, Wead LM, Blantz RC: Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J Am Soc Nephrol 5:1761-1767, 1995
37. 36a. Ruilope LM, Rodicio J, Robles RG, Sancho J, Miranda B, Granger JP, Romero JC: Influence of a low sodium diet on the renal response to amino acid infusions in humans. Kidney Int 31:992-999, 1987
38. Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am J Med 80:435-442, 1986
39. Mühlhauser I, Prange K, Sawicki P, Bender R, Dworschak A, Schaden W, Berger M: Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia 39:212-219, 1996
40. Anderson JV, Christofides ND, Bloom SR: Plasma release of atrial natriuretic peptide in response to blood volume expansion. J Endocrinol 109:9-13, 1986
41. Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA: Interaction between ANP and the renin angiotensin aldosterone system: endogenous antagonists. Am J Med 87:245-285, 1989
42. Ortola FV, Ballerman BJ, Anderson S, Mendez RE, Brenner BM: Elevated plasma atrial natriuretic peptide levels in diabetic rats. J Clin Invest 80:670-674, 1987
43. Kikkawa R, Haneda M, Sakamoto K, Koya D, Shikano T, Nakanishi S, Matsuda Y, Shigeta Y: Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats. Biochem Biophys Res Commun 193:700-705, 1993
44. Zhang PL, Mackenzie HS, Troy JL, Brenner BM: Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats. J Am Soc Nephrol 4:1564-1570, 1994
45. Cooper ME, Allen TJ, O'Brien R, Clarke B, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat: functional and structural characteristics. J Hypertension 6:1009-1016, 1988
46. Michels LD, O'Donnell MP, Keane WF: Glomerular hemodynamic and structural correlations in long-term experimental diabetic rats. J Lab Clin Med 103:840-847, 1984
47. Steffes MW, Brown DM, Basgen JM, Mauer SM: Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes 29:509-515, 1980
48. Michels LD, Davidman M, Keane WF: Determinants of glomerular filtration and plasma flow in experimental diabetic rats. J Lab Clin Med 98:869-885, 1981
49. Kumar AM, Gupta RK, Spitzer A: Intracellular sodium in proximal tubules of diabetic rats: role of glucose. Kidney Int 33:792-797, 1988
50. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
51. Ziyadeh FN: Role of transforming growth factor beta in diabetic nephropathy. Exp Nephrol 2:137, 1994
52. Ho MM, Vinson GP: Endocrine control of the distribution of basic fibroblast growth factor, insulin-like growth factor-I and transforming growth factor-β1 mRNAs in adult adrenals using non-radioactive in situ hybridization. J Endocrinol 144:379-387, 1995
53. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
54. Bach LA, Jerums G: Effect of puberty on initial renal growth and rise in kidney insulin-like growth factor 1 in diabetic rats. Diabetes 39:557-562, 1990
55. Anderson S: Antihypertensive therapy in experimental diabetes. J Am Soc Nephrol 3:S86-S90, 1992
56. Cooper ME, Allen TJ, O'Brien RC, Papazoglou D, Clarke BE, Jerums G, Doyle AE: Nephropathy in a model combining genetic hypertension with experimental diabetes. Diabetes 39:1575-1579, 1990
57. Morgan T, Gillies A, Morgan G, Adams W, Wilson M, Carney S: Hypertension treated by salt restriction. Lancet i:227-230, 1978
58. Freis ED: Salt, volume and hypertension. Circulation 53:589-595, 1976
59. O'Hare JA, Ferriss J, Twomey B, O'Sullivan JD: Essential hypertension and hypertension in diabetic patients without nephropathy. J Hypertension 1 (Suppl. 2):200-203, 1983
60. Tuck M, Corry D, Trujillo A: Salt sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 88:210-216, 1990
61. Strojek K, Grzeszczak W, Lacka B, Gorska J, Keller CK, Ritz E: Increased prevalence of salt sensitivity of blood pressure in IDDM with and without albuminuria. Diabetologia 38:1443-1448, 1995
62. Weidmann PC, Beretta-Piccoli G, Keusch G, Glueck Z, Mujagic M, Meier A, Ziegler WH: Sodium-volume factor, cardiovascular reactivity and hypotensive mechanisms of diuretic therapy in hypertension associated with diabetes mellitus. Am J Med 67:779-784, 1979
63. Feldt-Rasmussen B, Mathiesen ER, Deckert T: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitas. Diabetologia 30:610-617, 1987
64. Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG: Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. Br Med J 298:227-230, 1989
65. Bending JJ, Viberti, GC, Watkins, PJ, Keen H: Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J 292:83-86, 1986
66. Campbell DJ: Circulating and tissue angiotensin systems. J Clin Invest 79:1-6, 1987
67. Bruneval P, Hinglais N, Alhenc-Gelas F, Tricottet V, Corvol P, Menard J, Camilleri JP, Bariety J: Angiotensin I converting enzyme in human intestine and kidney. Histochemistry 85:73-80, 1986
68. Jerums G, Allen TJ, Tsalamandris C, Cooper ME, MDNS Group: Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. Kidney Int 41:904-911, 1992